1. 3D printed self-similar AlSi10Mg alloy hierarchical honeycomb architectures under in-plane large deformation. (July 2021) Authors: Zhang, Yuwu; Lin, Yuliang; Li, Ying; Li, Xiangcheng Journal: Thin-walled structures Issue: Volume 164(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A cross-scale study on the relationship between urban expansion and ecosystem services in China. (1st October 2022) Authors: Tian, Shiqi; Wu, Wei; Shen, Zhou; Wang, Jiao; Liu, Xueqing; Li, Linjuan; Li, Xiangcheng; Liu, Xiansheng; Chen, Hongshan Journal: Journal of environmental management Issue: Volume 319(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study. (3rd June 2021) Authors: Zhang, Yaodong; Wu, Zhengshan; Chang, Jiang; Jiang, Wangjie; Wang, Yirui; Wang, Hongwei; Li, Jinyang; Li, Changxian; Li, Xiangcheng Journal: Expert review of gastroenterology & hepatology Issue: Volume 15:Number 6(2021) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis on mechanism of explosive spalling resistance of aluminum powder on ladle corundum-based refractory castable. Issue 11 (1st August 2020) Authors: Wang, Zhiqiang; Li, Xiangcheng; Zhu, Boquan; Lei, Zhongxing; Peng, Xiaoqian; Wang, Yulong Journal: Ceramics international Issue: Volume 46:Issue 11(2020)Part B Page Start: 18958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection. Issue 2 (February 2015) Authors: Huang, Changjun; Tian, Yuan; Peng, Rui; Zhang, Changhe; Wang, Dong; Han, Sheng; Jiao, Chenyu; Wang, Xing; Zhang, Hai; Wang, Yun; Li, Xiangcheng Journal: Journal of gastroenterology and hepatology Issue: Volume 30:Issue 2(2015:Feb.) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of five genetic variations in DNMT1 and DNMT3A with gastric cancer in a Chinese population. (29th June 2018) Authors: Zhou, Jin; Wang, Zhibing; Zhang, Lei; Gu, Yuanyuan; Ma, Yong; Li, Xiangcheng Journal: Future oncology Issue: Volume 14:Number 17(2018) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗